These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Autoantibodies against N-methyl-d-aspartate receptor 1 in health and disease. Ehrenreich H Curr Opin Neurol; 2018 Jun; 31(3):306-312. PubMed ID: 29474316 [TBL] [Abstract][Full Text] [Related]
7. Anti-NMDA receptor encephalitis presenting as a primary psychotic disorder. Nelson MA; Lochhead JD; Maguire GA Ann Clin Psychiatry; 2017 Aug; 29(3):205-206. PubMed ID: 28738102 [No Abstract] [Full Text] [Related]
8. A case of anti-N-methyl-D-aspartate receptor encephalitis with systemic sclerosis. Suzuki H; Samukawa M; Kitada M; Ichihashi J; Mistui Y; Tanaka K; Kusunoki S Eur J Neurol; 2011 Nov; 18(11):e145-6. PubMed ID: 21985028 [No Abstract] [Full Text] [Related]
9. An anti-NMDA receptor encephalitis mimicking an HIV encephalitis. Haneche F; Demeret S; Psimaras D; Katlama C; Pourcher V Clin Immunol; 2018 Aug; 193():10-11. PubMed ID: 29772276 [TBL] [Abstract][Full Text] [Related]
10. Extreme delta brush in a patient with anti-NMDAR encephalitis. Di Capua D; García-Ptacek S; García-García ME; Abarrategui B; Porta-Etessam J; García-Morales I Epileptic Disord; 2013 Dec; 15(4):461-4. PubMed ID: 24317133 [TBL] [Abstract][Full Text] [Related]
11. Anti-N-Methyl-D-Aspartate-Receptor Encephalitis Complicated With Antiphospholipid Syndrome and Cerebral Venous Thrombosis. Hsu YW; Juan CJ; Lee JT; Lin YK; Lai CH; Yang FC J Clin Rheumatol; 2017 Aug; 23(5):294-295. PubMed ID: 28742728 [No Abstract] [Full Text] [Related]
13. Prevalence and treatment of anti-NMDA receptor encephalitis. Byrne S; Jordan I; Redmond J Lancet Neurol; 2013 May; 12(5):424. PubMed ID: 23602155 [No Abstract] [Full Text] [Related]
14. Detection of autoantibody against extracellular epitopes of N-methyl-D-aspartate receptor by cell-based assay. Takano S; Takahashi Y; Kishi H; Taguchi Y; Takashima S; Tanaka K; Muraguchi A; Mori H Neurosci Res; 2011 Nov; 71(3):294-302. PubMed ID: 21839784 [TBL] [Abstract][Full Text] [Related]
15. Anti-N-methyl-D-aspartate receptor-mediated encephalitis in infants and toddlers: case report and review of the literature. Goldberg EM; Titulaer M; de Blank PM; Sievert A; Ryan N Pediatr Neurol; 2014 Feb; 50(2):181-4. PubMed ID: 24315538 [TBL] [Abstract][Full Text] [Related]
16. [Acute encephalitis anti-ionotropic glutamate receptor activated N-methyl-D-aspartate (NMDAR): analysis of eleven pediatric cases in Argentina (Benito Yelín Award)]. Pérez E; Ruggieri V; Monges S; Loos M; Caraballo R; Yerga A; Rugilo C; Vincent A; Arroyo HA Medicina (B Aires); 2013; 73 Suppl 1():1-9. PubMed ID: 24072045 [TBL] [Abstract][Full Text] [Related]
17. Case 27-2018: A 3-Year-Old Boy with Seizures. Gorman MP; Gombolay GY; Mehan WA; Thibert RL N Engl J Med; 2018 Aug; 379(9):870-878. PubMed ID: 30157393 [No Abstract] [Full Text] [Related]
18. The importance of early and sustained treatment of a common autoimmune encephalitis. McKeon A Lancet Neurol; 2013 Feb; 12(2):123-5. PubMed ID: 23290629 [No Abstract] [Full Text] [Related]
19. Anti-N-methyl-D-aspartate receptor encephalitis relapse in the brainstem. Kobayashi Y; Sato S; Takasone K; Takamatsu R BMJ Case Rep; 2018 Apr; 2018():. PubMed ID: 29627783 [No Abstract] [Full Text] [Related]